Biotech · Public company · Carson City, NV, US

Biovie Inc.

Ticker BIVI · SEC CIK 0001580149

Track this companyFree. Adds Biovie Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials80 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

NE3107 in Adults With Neurological Symptoms of Long COVIDPHASE2 · COMPLETED · started Apr 29, 2025ClinicalTrials.gov NCT06847191 · fetched Nov 12, 2026
A Study of NE3107 in Early Parkinson'sPHASE2 · COMPLETED · started Mar 26, 2025ClinicalTrials.gov NCT06757010 · fetched Nov 12, 2026
Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain InjuryPHASE2 · TERMINATED · started Dec 21, 2023ClinicalTrials.gov NCT05970575 · fetched Nov 12, 2026
Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of DementiaPHASE2 · COMPLETED · started Jan 19, 2022ClinicalTrials.gov NCT05227820 · fetched Nov 12, 2026
NE3107 Activity and Safety in Patients With Parkinson's Disease Using LevodopaPHASE1_PHASE2 · COMPLETED · started Jan 4, 2022ClinicalTrials.gov NCT05083260 · fetched Nov 12, 2026
A Phase 3 Study of NE3107 in Probable Alzheimer's DiseasePHASE3 · COMPLETED · started Aug 5, 2021ClinicalTrials.gov NCT04669028 · fetched Nov 12, 2026
A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesPHASE2 · TERMINATED · started Jun 17, 2021ClinicalTrials.gov NCT04112199 · fetched Nov 12, 2026
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory AscitesPHASE2 · COMPLETED · started Jul 15, 2017ClinicalTrials.gov NCT03107091 · fetched Nov 12, 2026